Lilly(Eli) & Company
NYSE: LLY
$873.68
+$0.56 (+0.1%)
Closing Price on February 21, 2025
LLY Articles
AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
Published:
A stock split divides existing shares into multiple new ones, increasing a given company’s share count and making shares more affordable for those looking to buy in. For the same $10,000...
Published:
It’s no surprise that inflation over the past four years have sent the prices of goods and services steeply spiraling upwards. With certain food staples rising over 40-50%, gas and electricity...
Published:
There is a reason the Schwab US Dividend ETF (NYSEARCA:SCHD) is a top-of-list purchase for investors. It provides one of the easiest ways to buy the biggest dividend growth stocks in the U.S....
Published:
In the ever-changing world of investing, ETFs have become the go-to choice for many novice and seasoned investors. ETFs are “baskets” of stocks. When you buy an ETF, you’re investing in all the...
Published:
Last Updated:
Selecting stocks for the long haul can be a challenge. Here is what could be the best-performing stock in 2030 and why.
Published:
The pharmaceutical industry plays a crucial role in most of our everyday lives. From life-saving medication we need when we need it, to everyday pain remediation or allergy medications, big pharma...
Published:
Diversification is key in today’s investing world. Exchange-traded funds, or ETFs, offer a convenient and affordable way to achieve this. Think of them as baskets filled with a variety of stocks....
Published:
247 Wall St. Key Insights QQQ offers higher growth potential but comes with greater risk due to its reliance on tech stocks. VOO provides broad market exposure with lower risk and steady growth. ...
Published:
Pharma stocks have been on quite a nice run over the past year. A number of new catalysts have revitalized this sector, which I’m going to dive into with a few of these picks. Whether we’re...
Published:
Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what the company's prospects are for the next decade of growth.
Published:
Jim Cramer is probably the closest thing we have to stock market superstar influencer. The host of CNBC’s “Mad Money” show is entertaining and popular with a broad swath of investors who like...
Published:
Some of the best opportunities can still be found in obesity treatment stocks. Look at Viking Therapeutics (NASDAQ:VKTX), for example. Now trading at $57.80, we strongly believe it could easily rally...
Published:
As the high-growth trade fizzles out in September, even some top-tier secular growth plays will take an outsized hit to the chin. Undoubtedly, several investment themes, including generative AI and...
Published:
Biotech investing is a thrill-a-minute ride. Biotech stocks can take investors soaring to new heights and fabulous wealth opportunities or send them into the pits of despair. The drug discovery...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.